New Zealand - engelsk - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - salbutamol sulfate 120.5ug equivalent to 100 µg dose (10% excess may be added to compensate for manufacturing loss);   - aerosol inhaler, metered dose - 100 mcg/dose - active: salbutamol sulfate 120.5ug equivalent to 100 µg dose (10% excess may be added to compensate for manufacturing loss)   excipient: norflurane - salbutamol is a selective ?2 adrenoceptor agonist indicated for the treatment or prevention of bronchospasm. it provides short acting (four hours) bronchodilation in reversible airways obstruction due to asthma, chronic bronchitis and emphysema. for patients with asthma salbutamol may be used to relieve symptoms when they occur and to prevent them prior to a known trigger. bronchodilators should not be the only or main treatment in patients with persistent asthma. in patients with persistent asthma unresponsive to salbutamol, treatment with inhaled corticosteroids is recommended to achieve and maintain control. failure to respond promptly or fully to such rescue medication signals a need for urgent medical advice and treatment.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - salbutamol sulfate 120.525ug (equvalent to 100µg salbutamol anhydrous) - aerosol inhaler, metered dose - 100 mcg/dose - active: salbutamol sulfate 120.525ug (equvalent to 100µg salbutamol anhydrous) excipient: cryofluorane dichlorodifluoromethane sorbitan trioleate trichlorofluoromethane

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - salbutamol sulfate 120.525ug equivalent to 100 µg salbutamol anydrous - aerosol inhaler, metered dose - 100 mcg/dose - active: salbutamol sulfate 120.525ug equivalent to 100 µg salbutamol anydrous excipient: cryofluorane dichlorodifluoromethane sorbitan trioleate trichlorofluoromethane

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - salbutamol sulfate 120.5ug;   - powder for inhalation - 100 mcg/dose - active: salbutamol sulfate 120.5ug   excipient: lactose monohydrate

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

laboratorio aldo union s.l. - salbutamol sulfato - suspensiÓn para inhalaciÓn en envase a presiÓn - 100 microgramos/dosis - salbutamol sulfato 100 microgramos - salbutamol

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate -

Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

teva pharmaceuticals ltd, u.k. - ΤΟ salbutamol sulfate - ΑΕΡΟΛΥΜΑ ΓΙΑ ΕΙΣΠΝΟΗ, ΣΤΑΘΕΡΩΝ ΔΟΣΕΩΝ - 100mcg/dose - 0051022709 - salbutamol sulfate - 120.520000 - salbutamol

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

innovata biomed limited - salbutamol sulfato - polvo para inhalaciÓn - 100 microgramos/dosis - salbutamol sulfato 90 microgramos - salbutamol

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - salbutamol sulfate - oral tablet - 2mg

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - salbutamol sulfate - oral tablet - 2mg